[ad_1]
Bengaluru:
Biotechnology business veteran Kiran Mazumdar-Shaw has questioned Russian claims of growing the world’s first secure coronavirus vaccine, citing absence of information on scientific trials and “more advanced” programmes elsewhere.
The world has not seen any information on Phase 1 or 2 scientific trials performed by Moscow-based Gamaleya Research Institute, the Executive Chairperson of Bengaluru-headquartered Biocon Ltd mentioned.
“If launching a vaccine prior to completion of Phase 3 trials is acceptable to Russia, well so be it,” Ms Mazumdar-Shaw informed PTI.
“But it doesn’t make them the world’s first vaccine as several other vaccine programmes are even more advanced,” she added.
Russia introduced on Tuesday it had change into the primary nation to grant regulatory approval to a COVID-19 vaccine.
The first dose of the vaccine-Sputnik-V, developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry, was administered to Russian President Vladimir Putin’s daughter.
(This story has not been edited by NDTV employees and is auto-generated from a syndicated feed.)
[ad_2]
Source hyperlink